• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (43)
    • The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence.
    • Baltic States
    • The utility of the ankle SPECT/CT scan to predict functional and clinical outcomes in supramalleolar osteotomy patients.
    • Alternate splicing pathways of the immunoglobulin heavy chain transcript of a teleost fish, Ictalurus punctatus.
    • KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
    • See All 43 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.

KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.

View in: PubMed

subject areas
  • Breast Neoplasms
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Chromosomes, Human, Pair 8
  • Cluster Analysis
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Histone Acetyltransferases
  • Humans
  • Neoplastic Stem Cells
  • Oncogenes
  • Prognosis
  • Protein Binding
  • Receptor, Fibroblast Growth Factor, Type 2
  • RNA Interference
  • Spheroids, Cellular
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay

authors with profiles
  • Elizabeth Garrett Garrett-Mayer
  • Stephen P. Ethier
  • Robert C Wilson
  • Christiana S. Kappler